EarningsQ2 2026 Earnings Report
DE:GIN1 Q2 2026 EPS Results
Actual EPS€1.17
Consensus EPS―
Beat/Miss―
One Year Ago EPS€1.33
DE:GIN1 Q2 2026 Revenue Results
Actual Revenue€4.31B
Expected Revenue―
Beat/Miss―
YoY Revenue Growth+7.73%
Earnings Announcement Details
QuarterQ2 2026
Date07/23/2026
TimeBefore Open
Conference CallThursday, July 23, 2026
DE:GIN1 Upcoming Earnings
Givaudan SA's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:GIN1 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed a balanced message: solid operational momentum (notably in Fragrance & Beauty and Asia), clear signs of sequential recovery in Taste & Wellbeing, continued investment in innovation and sustainability, and re-affirmation of medium-term 2030 targets. Offsetting these positives were material nonrecurring litigation and provision charges (CHF 103m), weaker reported net income and EPS, negative adjusted free cash flow in H1, higher net debt/leverage and elevated working capital. Management expressed confidence in normalization of working capital, improved cash generation in H2 and delivery against the 2030 strategic ambitions, but the near-term financial impacts of one-offs and regional softness leave the picture mixed.Company Guidance
Group Sales Growth (Like-for-Like)
Group sales of CHF 3,799m in H1 2026, up 3.6% like-for-like (reported -1.7% in CHF due to Swiss franc strength). Growth was primarily volume-led and broadly balanced across customer groups and geographies.
Strong Fragrance & Beauty Performance
Fragrance & Beauty sales CHF 2,010m, +6.5% like-for-like and +2.9% in CHF. Fine Fragrance LFL +7.3% and Consumer Products LFL +9.2%, with broad-based demand across geographies and customer segments.
Sequential Recovery in Taste & Wellbeing
Taste & Wellbeing recorded EUR 1,789m, +0.5% like-for-like for the half with a clear sequential improvement (Q1 LFL -0.4% to Q2 LFL +1.5%), indicating early traction from optimization and commercial actions.
Resilient Regional Momentum
High-growth markets up 5.2% like-for-like and mature markets up 2.0% LFL. Asia Pacific grew strongly at +9.2% LFL (notably China and India). North America group-level LFL +2.3%.
Adjusted Profitability Remains Industry-Leading
Adjusted EBITDA of CHF 923m and adjusted EBITDA margin of 24.3% in H1 2026 (adjusted for one-offs), remaining at an elevated profitability level despite headwinds (prior year adjusted margin 25.2%).
Sustainability and Strategic Footprint Investments
Secured seventh consecutive CDP for climate action and CDP for supply engagement. Broke ground on expanded fragrance complex in Mexico and opened a new production site in Cikarang, Indonesia, supporting regional growth.
Innovation and Commercial Wins
Launched new science-led assets (e.g., PRIMALHYAL NeuroYouth), strategic investment in Microcaps AG for microencapsulation, opened House of Lime co-creation space, and developed GLP-1 related reformulation solutions and hot/spicy flavor technologies.
Confirmed 2030 Strategic Targets
Management re-affirmed 2030 ambitions: 4%–6% like-for-like sales growth and adjusted free cash flow margin above 12% on average over the 2026–2030 strategic cycle.
DE:GIN1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed